The global age-related macular degeneration market reached a valuation of US$ 11 Billion by 2022. Furthermore, across the 2022-2032 period of assessment, growth is expected to accelerate at a whopping 6.2% CAGR, reaching US$ 20 Billion.
Age-related macular degeneration (AMD), often known as macular degeneration is a disorder that causes loss of central vision owing to thinning of the retina’s macula. Age-related macular degeneration is more common in the elderly population and can result in irreversible visual loss in persons over the age of 60.
Download Sample Copy of This Report: –https://www.factmr.com/connectus/sample?flag=S&rep_id=7976?PJ
Market Players: –
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Bayer AG
- Pfizer Inc.
- Bausch Health Companies Inc.
- Regeneron Pharmaceuticals Inc.
- Amgen Inc.
- Biogen
- Samsung Bioepis
The examiners have utilized various vast conspicuous business knowledge devices to unite realities, figures, and market information into income assessments and projections in the Market.
Age-related Macular Degeneration Market- Competitive Landscape
Prominent players in the Age-related Macular Degeneration Industry are taking advantage of the rapidly increasing demand for the Age-related Macular Degeneration in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale vendors. Some prominent market developments are as follows :
- In November 2022, Bayer announced today the acquisition of Targenomix, a German biotech start-up. The Max Planck Institute for Molecular Plant Physiology (MPI MPP) spin-off identifies new mechanisms of action for crop protection chemicals using modern systems biology and computational life science technologies. Targenomix’s expertise, personnel, and platforms will be critical in delivering on Bayer’s commitment to the design of safe and effective molecules, as well as in accelerating the discovery and development of molecules with the potential to make agricultural production more sustainable in the face of dynamic challenges such as climate change and increasing weed, disease, and insect resistance.
What Do You Get in a Fact.MR Study?
- Factors affecting the overall development of the global Age-related Macular Degeneration Market
- Factor that might restrain the growth of the global market in the coming years of the forecast period.
- What is present competitive scenario of the global Age-related Macular Degeneration Market and its intricate details concerning potential business prospects of leading market players
- Pricing strategies of several different market players in the global Age-related Macular Degeneration Market
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
- EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
- CIS & Russia
- Japan
- Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7976?PJ
How Fact.MR Assists in Making Strategic Moves?
The data provided in the Age-related Macular Degeneration Market report offers comprehensive analysis of important industry trends. Industry players can use this data to strategize their potential business moves and gain remarkable revenues in the upcoming period.
The report covers the price trend analysis and value chain analysis along with analysis of diverse offering by market players. The main motive of this report is to assist enterprises to make data-driven decisions and strategize their business moves.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com